Amgen Inc (AMGN)-Medical Equipment-Deals and Alliances Profile

Amgen Inc (AMGN)-Medical Equipment-Deals and Alliances Profile


  • Products Id :- GDME3778D
  • |
  • Pages: 74
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Amgen Inc (Amgen) is a biotechnology company that discovers, develops, manufactures and markets innovative human therapeutics to improve the lives of patients suffering from serious diseases. It develops novel medicines in six focused therapeutic areas including cardiovascular disease, oncology/hematology, inflammation, bone health, neuroscience and nephrology. The company develops products by using advanced human genetics to unravel the difficulties of disease and understand the fundamentals of human biology. Amgen sells its products primarily to pharmaceutical wholesale distributors in the US. It also markets certain products directly to consumers by television advertising, direct-to-consumer print and multi-channel marketing. Amgen is headquartered in Thousand Oaks, California, the US.

Amgen Inc (AMGN)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company financial deals that enable you to understand the company expansion/divestiture and fund requirements

The profile enables you to analyze the company financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company business segments' expansion / divestiture strategy

The profile presents deals from the company core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Amgen Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6

Amgen Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7

Amgen Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8

Amgen Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 9

Amgen Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10

Amgen Inc, Medical Equipment, Deal Details 12

Venture Financing 12

Gamida Cell Raises US$10 Million In Series E Financing 12

Partnerships 13

Adaptive Biotech Enters into Agreement with Amgen 13

Biocartis Partners with Amgen 14

Exosome Diagnostics Enters into Agreement with Amgen 15

Flatiron Health Partners with Amgen 15

Biocartis Enters into Agreement with Amgen 16

Dako Enters into Co-Development Agreement with Amgen for Companion Diagnostic 17

Dako Enters Into Co-Development Agreement With Amgen For Molecular Diagnostic Test 17

Illumina Enters Into Co-Development Agreement With Amgen For Oncology Companion Diagnostic Test 18

KineMed Enters Into Co-Development Agreement With Amgen For Kinetic Biomarkers Of Brain Proteinopathies 19

Transgenomic Enters Into Co-Development Agreement With Amgen For IVD Test 20

Dako Enters Into Co-Development Agreement With Amgen 21

Dako Enters Into Co-Development Agreement With Amgen 22

Warnex Medical Labs Enters Into Distribution Agreement With deCODE genetics 23

Merger 23

AstraZeneca Rumored To Merge With Amgen 23

Amgen Enters into Licensing Agreement with Unilife 24

Atara Biotherapeutics Enters Into Licensing Agreement with Amgen 25

Debt Offering 26

Unilife Raises USD30 Million in First Tranche of Private Placement of 6% Senior Secured Convertible Notes Due 2023 26

Amgen Raises USD1.4 Billion in Public Offering of Notes Due 2024 27

Amgen Raises USD600 Million in Public Offering of Floating Notes Due 2017 28

Amgen Raises USD250 Million in Public Offering of Floating Notes Due 2019 30

Amgen Raises USD1.4 Billion in Public Offering of Notes Due 2019 31

Amgen Raises USD850 Million in Public Offering of Notes Due 2017 33

Acquisition 34

Amgen Completes Acquisition Of Decode Genetics, Human Genetics Company, For US$401 Million 34

Amgen Inc-Key Competitors 37

Key Employees 38

Locations And Subsidiaries 40

Head Office 40

Other Locations & Subsidiaries 40

Recent Developments 47

Strategy And Business Planning 47

Jun 02, 2017: Amgen Showcases A Legacy Of Science, Innovation And Collaboration In Cambridge 47

Financial Announcements 48

Apr 26, 2017: Amgen Reports First Quarter 2017 Financial Results 48

Feb 02, 2017: Amgen Reports Fourth Quarter And Full Year 2016 Financial Results 51

Oct 27, 2016: Amgen Reports Third Quarter 2016 Financial Results 54

Jul 27, 2016: Amgen Reports Second Quarter 2016 Financial Results 57

Apr 28, 2016: Amgen First Quarter 2016 Revenues Increased 10 Percent To $5.5 Billion And Adjusted Earnings Per Share (EPS) Increased 17 Percent To $2.90 60

Jan 28, 2016: Amgen 2015 Revenues Increased 8 Percent To $21.7 Billion And Adjusted Earnings Per Share Increased 19 Percent To $10.38 62

Corporate Communications 64

Feb 03, 2017: Amgen Announces Appointment of Charles M. Holley Jr. to Board of Directors 64

Nov 02, 2016: Amgen Appoints Lori Johnston As Senior Vice President, Human Resources 65

Oct 14, 2016: Amgen Announces Appointment Of Ellen J. Kullman To Board Of Directors 66

Jun 17, 2016: Amgen Appoints Esteban Santos Executive Vice President, Operations 67

Legal and Regulatory 68

Jul 20, 2016: Amgen Announces Settlement Of Securities Litigation 68

Product News 69

Oct 17, 2016: West to Showcase Expertise in Injectable Drug Containment and Delivery at PDA Universe of Pre-filled Syringes & Injection Devices 69

Other Significant Developments 71

Mar 29, 2017: Amgen Enters into Agreement with Inovalon and Avalere to Engage Value-based Contracting Opportunities 71

Jan 09, 2017: DaVita Enters Into New Sourcing and Supply Agreement with Amgen and Initiates 2017 Kidney Care Guidance 72

Feb 12, 2016: West Daikyo Crystal Zenith Cyclic Olefin Polymer Selected by Amgen 73

Appendix 74

Methodology 74

About GlobalData 74

Contact Us 74

Disclaimer 74

List of Figures

Amgen Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 1

Amgen Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 1

Amgen Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 1

Amgen Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 1

Amgen Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6

Amgen Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 7

Amgen Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8

Amgen Inc, Medical Equipment, Deals by Market, 2011 to YTD 2017 9

List of Tables

Amgen Inc, Medical Equipment, Key Facts, 2016 1

Amgen Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 1

Amgen Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6

Amgen Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7

Amgen Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8

Amgen Inc, Deals By Market, 2011 to YTD 2017 9

Amgen Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10

Gamida Cell Raises US$10 Million In Series E Financing 12

Adaptive Biotech Enters into Agreement with Amgen 13

Biocartis Partners with Amgen 14

Exosome Diagnostics Enters into Agreement with Amgen 15

Flatiron Health Partners with Amgen 15

Biocartis Enters into Agreement with Amgen 16

Dako Enters into Co-Development Agreement with Amgen for Companion Diagnostic 17

Dako Enters Into Co-Development Agreement With Amgen For Molecular Diagnostic Test 17

Illumina Enters Into Co-Development Agreement With Amgen For Oncology Companion Diagnostic Test 18

KineMed Enters Into Co-Development Agreement With Amgen For Kinetic Biomarkers Of Brain Proteinopathies 19

Transgenomic Enters Into Co-Development Agreement With Amgen For IVD Test 20

Dako Enters Into Co-Development Agreement With Amgen 21

Dako Enters Into Co-Development Agreement With Amgen 22

Warnex Medical Labs Enters Into Distribution Agreement With deCODE genetics 23

AstraZeneca Rumored To Merge With Amgen 23

Amgen Enters into Licensing Agreement with Unilife 24

Atara Biotherapeutics Enters Into Licensing Agreement with Amgen 25

Unilife Raises USD30 Million in First Tranche of Private Placement of 6% Senior Secured Convertible Notes Due 2023 26

Amgen Raises USD1.4 Billion in Public Offering of Notes Due 2024 27

Amgen Raises USD600 Million in Public Offering of Floating Notes Due 2017 28

Amgen Raises USD250 Million in Public Offering of Floating Notes Due 2019 30

Amgen Raises USD1.4 Billion in Public Offering of Notes Due 2019 31

Amgen Raises USD850 Million in Public Offering of Notes Due 2017 33

Amgen Completes Acquisition Of Decode Genetics, Human Genetics Company, For US$401 Million 34

Amgen Inc, Key Competitors 37

Amgen Inc, Key Employees 38

Amgen Inc, Other Locations 40

Amgen Inc, Subsidiaries 42

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Amgen Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

select a license

Single User License
USD 250 INR 16090
Site License
USD 500 INR 32180
Corporate User License
USD 750 INR 48270

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com